DK1171123T3 - Fremgangsmåde til behandling af nervecelledöd - Google Patents
Fremgangsmåde til behandling af nervecelledödInfo
- Publication number
- DK1171123T3 DK1171123T3 DK01906242T DK01906242T DK1171123T3 DK 1171123 T3 DK1171123 T3 DK 1171123T3 DK 01906242 T DK01906242 T DK 01906242T DK 01906242 T DK01906242 T DK 01906242T DK 1171123 T3 DK1171123 T3 DK 1171123T3
- Authority
- DK
- Denmark
- Prior art keywords
- cell death
- nerve cell
- treating nerve
- treating
- death
- Prior art date
Links
- 230000030833 cell death Effects 0.000 title 1
- 210000002569 neuron Anatomy 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51195200A | 2000-02-23 | 2000-02-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1171123T3 true DK1171123T3 (da) | 2006-12-04 |
Family
ID=24037094
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK01906242T DK1171123T3 (da) | 2000-02-23 | 2001-02-23 | Fremgangsmåde til behandling af nervecelledöd |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US6423739B1 (is) |
| EP (1) | EP1171123B1 (is) |
| JP (1) | JP2003523385A (is) |
| KR (1) | KR20010110798A (is) |
| CN (1) | CN1362877A (is) |
| AR (1) | AR030551A1 (is) |
| AT (1) | ATE336246T1 (is) |
| AU (1) | AU784418B2 (is) |
| BR (1) | BR0104586A (is) |
| CA (1) | CA2368352C (is) |
| DE (1) | DE60122252T2 (is) |
| DK (1) | DK1171123T3 (is) |
| ES (1) | ES2270981T3 (is) |
| HK (1) | HK1047038A1 (is) |
| ID (1) | ID30377A (is) |
| IL (1) | IL145799A (is) |
| MX (1) | MXPA01010749A (is) |
| NO (1) | NO321911B1 (is) |
| TW (1) | TWI289060B (is) |
| WO (1) | WO2001062246A1 (is) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040077709A1 (en) * | 1999-05-31 | 2004-04-22 | Daiichi Pharmaceutical Co., Ltd. | Neuronal death inhibitors |
| CA2433039C (en) * | 2000-12-28 | 2010-06-08 | Daiichi Pharmaceutical Co., Ltd. | Agent for therapeutic and prophylactic treatment of neuropathic pain |
| ATE404192T1 (de) * | 2001-08-22 | 2008-08-15 | Hamilton Pharmaceuticals Inc | Verwendung von nefiracetam zur behandlung von postischemischer neurodegeneration |
| US20060241144A1 (en) * | 2005-04-20 | 2006-10-26 | Albert Cha | Method for treating apathy syndrome |
| NO2490685T3 (is) | 2009-10-22 | 2018-05-12 | ||
| RU2480214C1 (ru) * | 2011-09-22 | 2013-04-27 | Валентина Ивановна Ахапкина | Состав, обладающий модуляторной активностью с соразмерным влиянием, фармацевтическая субстанция (варианты), применение фармацевтической субстанции, фармацевтическая и парафармацевтическая композиция (варианты), способ получения фармацевтических составов |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2469995A (en) * | 1946-07-23 | 1949-05-10 | Schaul Martin Carl | Process for the production of food preparations from potatoes and similar farinaceoustubers |
| US3031314A (en) * | 1960-03-16 | 1962-04-24 | Carl E Hendel | Preparation of dehydrated potatoes |
| US3260607A (en) * | 1961-02-07 | 1966-07-12 | Canadian Patents Dev | Preparation of dehydrated cooked mashed potato |
| US3968265A (en) * | 1973-02-01 | 1976-07-06 | American Potato Company | Freeze-thaw stable, french fry potato product and process for producing the same |
| DE2924011C2 (de) | 1979-06-13 | 1982-04-08 | A. Nattermann & Cie GmbH, 5000 Köln | Pyrrolidin-(2)-on-(1)-ylessigsäure-2,6,-dimethylanilid, Verfahren zur Herstellung und Arzneimittel, welche diese Verbindung enthalten |
| IT1141287B (it) | 1979-06-13 | 1986-10-01 | Nattermann A & Cie | Ammidi di acidi pirrolidin-(2)-on-(1)-ilalchil-carbossilici,procedimento per la loro preparazione e prodotti medicinali che le contengono |
| DE2923975A1 (de) | 1979-06-13 | 1980-12-18 | Nattermann A & Cie | Pyrrolidinone, verfahren zu deren herstellung und diese enthaltende arzneimittel |
| CZ281170B6 (cs) | 1991-05-02 | 1996-07-17 | Daiichi Pharmaceutical Co., Ltd | Léčivo pro léčení demence |
| US5525058A (en) | 1992-03-27 | 1996-06-11 | American Dental Technologies, Inc. | Dental treatment system |
| EP0785599B1 (en) | 1995-07-10 | 2000-12-13 | Kodera Electronics Co., Ltd. | Device for inserting a wire to be worked on |
| US6107330A (en) | 1995-08-07 | 2000-08-22 | Daiichi Pharmaceutical Co., Ltd. | Inhibitor for narcotic analgesic dependence/resistance acquisition |
| JP2002241272A (ja) | 1996-07-18 | 2002-08-28 | Mitsubishi Pharma Corp | 医薬処方組成物 |
| ES2185963T3 (es) | 1996-07-30 | 2003-05-01 | Ecolab Gmbh & Co Ohg | Agente filmogeno para la proteccion contra infecciones. |
| CA2267375A1 (en) | 1996-10-01 | 1998-04-09 | Mitsunobu Yoshii | Mitochondrial membrane stabilizer |
| US6211701B1 (en) | 1996-12-16 | 2001-04-03 | Rose Research, Llc | Low power line switching circuit, device and method |
| IT1293533B1 (it) | 1997-07-14 | 1999-03-01 | Angeletti P Ist Richerche Bio | Metodo per la selezione di molecole in grado di mimare, inibire o potenziare gli effetti della interazione tra leptina e cellule che |
| US6281242B1 (en) | 1997-07-15 | 2001-08-28 | Daiichi Pharmaceutical Co., Ltd. | Prophylactic or therapeutic agent for amnesia |
| JPH1180027A (ja) | 1997-09-12 | 1999-03-23 | Dai Ichi Seiyaku Co Ltd | 向知性薬 |
| TW544311B (en) | 1998-08-06 | 2003-08-01 | Daiichi Seiyaku Co | Therapeutic or preventive agent for intractable epilepsies |
| AU5102900A (en) | 1999-05-31 | 2000-12-18 | Daiichi Pharmaceutical Co., Ltd. | Neuronal death inhibitors |
-
2001
- 2001-02-16 US US09/784,048 patent/US6423739B1/en not_active Expired - Fee Related
- 2001-02-21 AR ARP010100761A patent/AR030551A1/es unknown
- 2001-02-23 EP EP01906242A patent/EP1171123B1/en not_active Expired - Lifetime
- 2001-02-23 JP JP2001561312A patent/JP2003523385A/ja active Pending
- 2001-02-23 BR BR0104586-5A patent/BR0104586A/pt not_active Application Discontinuation
- 2001-02-23 DE DE60122252T patent/DE60122252T2/de not_active Expired - Lifetime
- 2001-02-23 AT AT01906242T patent/ATE336246T1/de not_active IP Right Cessation
- 2001-02-23 ID IDW00200102283A patent/ID30377A/id unknown
- 2001-02-23 ES ES01906242T patent/ES2270981T3/es not_active Expired - Lifetime
- 2001-02-23 CA CA002368352A patent/CA2368352C/en not_active Expired - Fee Related
- 2001-02-23 DK DK01906242T patent/DK1171123T3/da active
- 2001-02-23 TW TW090104150A patent/TWI289060B/zh not_active IP Right Cessation
- 2001-02-23 AU AU34145/01A patent/AU784418B2/en not_active Ceased
- 2001-02-23 KR KR1020017013542A patent/KR20010110798A/ko active Search and Examination
- 2001-02-23 MX MXPA01010749A patent/MXPA01010749A/es active IP Right Grant
- 2001-02-23 WO PCT/JP2001/001342 patent/WO2001062246A1/en active IP Right Grant
- 2001-02-23 CN CN01800298A patent/CN1362877A/zh active Pending
- 2001-02-23 IL IL145799A patent/IL145799A/en not_active IP Right Cessation
- 2001-07-17 US US09/906,077 patent/US6399650B2/en not_active Expired - Fee Related
- 2001-10-22 NO NO20015162A patent/NO321911B1/no unknown
-
2002
- 2002-11-28 HK HK02108589.8A patent/HK1047038A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO20015162D0 (no) | 2001-10-22 |
| DE60122252D1 (de) | 2006-09-28 |
| AU784418B2 (en) | 2006-03-30 |
| BR0104586A (pt) | 2002-01-08 |
| KR20010110798A (ko) | 2001-12-13 |
| US6423739B1 (en) | 2002-07-23 |
| AU3414501A (en) | 2001-09-03 |
| IL145799A0 (en) | 2002-07-25 |
| NO321911B1 (no) | 2006-07-17 |
| ATE336246T1 (de) | 2006-09-15 |
| US6399650B2 (en) | 2002-06-04 |
| DE60122252T2 (de) | 2007-07-05 |
| EP1171123B1 (en) | 2006-08-16 |
| CA2368352C (en) | 2009-11-10 |
| TWI289060B (en) | 2007-11-01 |
| IL145799A (en) | 2006-10-31 |
| CN1362877A (zh) | 2002-08-07 |
| ES2270981T3 (es) | 2007-04-16 |
| AR030551A1 (es) | 2003-08-27 |
| ID30377A (id) | 2001-11-29 |
| MXPA01010749A (es) | 2002-08-20 |
| WO2001062246A1 (en) | 2001-08-30 |
| NO20015162L (no) | 2001-12-21 |
| EP1171123A1 (en) | 2002-01-16 |
| US20010051653A1 (en) | 2001-12-13 |
| US20020055534A1 (en) | 2002-05-09 |
| JP2003523385A (ja) | 2003-08-05 |
| HK1047038A1 (zh) | 2003-02-07 |
| CA2368352A1 (en) | 2001-08-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1249151T3 (da) | Fremgangsmåde til cellegenvalgssignalering | |
| DK1132569T3 (da) | Fremgangsmåde til behandling af en underjordisk formation | |
| DK3167872T3 (da) | Fremgangsmåder til behandling af inflammationsmedierede tilstande i øjet | |
| NO20030241D0 (no) | Fremgangsmåte for behandling av multiple brönnintervaller | |
| DK2283867T3 (da) | Fremgangsmåder til behandling ved anvendelse af anti-ErbB antistof-maytansinoidkonjugater | |
| DK1121192T3 (da) | Fremgangsmåde til homogenisering | |
| DK1390014T3 (da) | Sammensætning til anvendelse i en fremgangsmåde til behandling af hyperplasi | |
| DE60044004D1 (de) | Verwendung von Omega-Carboxyaryl-substituierten Diphenylharnstoffen als raf-Kinase-Inhibitoren | |
| DE60124301D1 (de) | Dünnschichtelektroden zum feststellen von herzdepolarisationsignalen | |
| EE05430B1 (et) | Imidasolo-5-l-2-anilino-primidiinid raku proliferatsiooni inhibitsiooni agensitena | |
| DK1132570T3 (da) | Sammensætninger til syrebehandling af borebrönde | |
| IS2532B (is) | Aðferð til að afsalta sjó | |
| ID25682A (id) | Metode untuk melelehkan kaca | |
| DK1091086T3 (da) | Vandige gelerede sammensætninger til behandling af borebrönde | |
| IS6521A (is) | Aðferð til að hreinsa gerjunarseyði | |
| NO20005318D0 (no) | FremgangsmÕter og anordninger ved behandling av vann | |
| DE60128788D1 (de) | Zusammensetzung und verfahren zur bekämpfung von pflanzenschädlichen arthropoden | |
| DK2189162T3 (da) | Fremgangsmåder til behandling af cellulære proliferative forstyrrelser | |
| DK1414492T3 (da) | Fremgangsmåde til behandling af multipel myeloma | |
| DK1539200T3 (da) | Fremgangsmåde til behandling af multipel sklerose | |
| DK1314824T3 (da) | Fremgangsmåde til konsolidering af jord | |
| DK1461047T3 (da) | Sammensætninger og fremgangsmåde til behandling af dyr | |
| IS5742A (is) | Aðferð til genalækninga | |
| DK1105136T3 (da) | Fremgangsmåde til behandling af okulære neovaskulære sygdomme | |
| DK1294659T3 (da) | Fremgangsmåde til isolering af katamin |